Published in Ann N Y Acad Sci on June 06, 1994
High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans. Science (1989) 3.00
Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method. J Virol (1989) 2.67
Identification of the gene responsible for human T-cell leukaemia virus transcriptional regulation. Nature (1986) 2.49
The x gene is essential for HTLV replication. Science (1985) 2.44
A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med (1986) 1.44
Detection and cloning of new HTLV-related endogenous sequences in man. Nucleic Acids Res (1989) 1.36
Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. Blood (1994) 1.33
Patterns of repair of dystrophic mouse muscle: studies on isolated fibers. Dev Dyn (1999) 1.29
Human T-cell leukemia viruses: epidemiology, biology, and pathogenesis. Blood Rev (1997) 1.22
Activation of the GM-CSF promoter by HTLV-I and -II tax proteins. Oncogene (1989) 1.22
Aging normal and dystrophic mouse muscle: analysis of myogenicity in cultures of living single fibers. Muscle Nerve (1998) 1.21
Lentivirus vectors using human and simian immunodeficiency virus elements. J Virol (1999) 1.15
Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet (1991) 1.12
A histochemical method for the simultaneous demonstration of capillaries and fiber type in skeletal muscle. Stain Technol (1987) 1.07
Establishment of human T-cell leukemia virus type I T-cell lymphomas in severe combined immunodeficient mice. Blood (1993) 1.06
Regulation of HTLV-II gene expression by Rex involves positive and negative cis-acting elements in the 5'long terminal repeat. Virology (1991) 1.04
Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements. J Virol (1995) 1.03
Human T-cell leukemia virus type II Rex binding and activity require an intact splice donor site and a specific RNA secondary structure. J Virol (1991) 1.03
In vitro mutagenesis of the human T-cell leukemia virus types I and II tax genes. J Virol (1989) 1.03
Specific binding of polypyrimidine tract binding protein and hnRNP A1 to HIV-1 CRS elements. Virus Genes (1996) 1.02
Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr. Exp Cell Res (1999) 0.99
Mutation of the methylated tRNA(Lys)(3) residue A58 disrupts reverse transcription and inhibits replication of human immunodeficiency virus type 1. J Virol (2001) 0.97
Inhibition of HIV-1 replication using a mutated tRNALys-3 primer. J Biol Chem (1997) 0.95
In vivo properties of three human HER2/neu-expressing murine cell lines in immunocompetent mice. Lab Anim Sci (1999) 0.95
Ectopic skeletal muscles derived from myoblasts implanted under the skin. J Cell Sci (1998) 0.94
Viral gene delivery to skeletal muscle: insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors. Hum Gene Ther (1997) 0.94
Serological and molecular survey for HTLV-I infection in a high-risk Middle Eastern group. Lancet (1991) 0.93
HTLV-I and HTLV-II tax trans-activate the human EGR-1 promoter through different cis-acting sequences. Oncogene (1992) 0.91
Human T-cell leukemia virus type 2 Rex inhibits pre-mRNA splicing in vitro at an early stage of spliceosome formation. J Virol (1996) 0.89
Detection of mutated K12-ras in histologically negative lymph nodes as an indicator of poor prognosis in stage II colorectal cancer. Clin Colorectal Cancer (2001) 0.89
Inhibition of HIV type 1 infection with a RANTES-IgG3 fusion protein. AIDS Res Hum Retroviruses (1998) 0.87
A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma. Cancer Gene Ther (2003) 0.87
Hypercalcemia, parathyroid hormone-related protein expression and human T-cell leukemia virus infection. Leuk Lymphoma (1994) 0.87
Slow axonal regrowth but extreme hyperinnervation of target muscle after suture of the facial nerve in aged rats. Neurobiol Aging (1998) 0.86
Adult T-cell lymphoma in Israeli patients of Iranian origin. Cancer (1990) 0.85
A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme. Hum Gene Ther (1999) 0.85
Lentiviral vectors and gene therapy. Front Biosci (1999) 0.84
Eradication of pre-established lymphoma using herpes simplex virus amplicon vectors. Blood (1999) 0.83
A colony assay for in vitro transformation by human T cell leukemia viruses type I and type II. Blood (1987) 0.82
Binding of nuclear proteins to HTLV-II cis-acting repressive sequence (CRS) RNA correlates with CRS function. Virology (1994) 0.81
Cell type-specific activity of the N-myc promoter in human neuroblastoma cells is mediated by a downstream silencer. Oncogene (1995) 0.81
A B7.1-antibody fusion protein retains antibody specificity and ability to activate via the T cell costimulatory pathway. J Immunol (1998) 0.81
Effects of the farnesyl transferase inhibitor R115777 on normal and leukemic hematopoiesis. Leukemia (2003) 0.80
The rheumatoid factor reactivity of a human IgG monoclonal autoantibody is encoded by a variant V kappa II L chain gene. J Immunol (1991) 0.80
Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells. Oncogene (1992) 0.79
2-Chlorodeoxyadenosine to treat refractory histiocytosis X. N Engl J Med (1993) 0.79
Effects of megakaryocyte growth and development factor on survival and retroviral transduction of T lymphoid progenitor cells. Hum Gene Ther (1998) 0.79
Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia. Blood (2001) 0.79
A murine B cell lymphoma expressing human HER2 / neu undergoes spontaneous tumor regression and elicits antitumor immunity. Cancer Immunol Immunother (2001) 0.78
Selection and use of ligands for receptor-mediated gene delivery to myogenic cells. Gene Ther (1997) 0.77
Forced MyHCIIB expression following targeted genetic manipulation of conditionally immortalized muscle precursor cells. Exp Cell Res (1999) 0.77
The effect of intraoperative ischemia on the recovery of contractile function after free muscle transfer. J Hand Surg Am (1988) 0.77
Immunopathogenesis of HIV and HTLV-1 infection: mechanisms for lymphomagenesis. Cancer Treat Res (2001) 0.76
A RANTES-antibody fusion protein retains antigen specificity and chemokine function. J Immunol (1998) 0.76
A patient with progressive myelopathy and antibodies to human T-cell leukemia virus type I and human immunodeficiency virus type 1 in serum and cerebrospinal fluid. Arch Neurol (1990) 0.76
Brentuximab vedotin does not cause clinically relevant QTc interval prolongation in patients with CD30-positive hematologic malignancies. Cancer Chemother Pharmacol (2013) 0.75
A comparative histochemical and morphometric study of canine skeletal muscle. Can J Vet Res (1989) 0.75
Elevated serum interleukin-2 receptors in a newly identified group with high rates of human T cell leukemia virus type I infection in Israel. J Infect Dis (1991) 0.75
A Phase I study of human gamma interferon gene-transduced tumor cells in patients with neuroblastoma. Hum Gene Ther (1998) 0.75
Molecular analysis of childhood acute lymphoblastic leukemia in Israel. Leuk Res (1998) 0.75
The role of the x gene in HTLV associated malignancy. Cancer Surv (1986) 0.75
Parathyroid hormone-related protein gene expression and human T cell leukemia virus-1 infection. Miner Electrolyte Metab (1995) 0.75
Detection of human T-cell leukemia/lymphoma virus type I in a transfusion recipient with chronic myelopathy. Neurology (1989) 0.75
CD-20 expression in post-transplant lymphoproliferative disorders: treatment with rituximab. Am J Hematol (2000) 0.75
Skeletal muscle fiber type, fiber size, and capillary supply in elite soccer players. Int J Sports Med (1990) 0.75
[Human T cell lymphoma/leukemia virus type I]. Harefuah (1994) 0.75
Negative regulation of gene expression from the HTLV type II long terminal repeat by Rex: functional and structural dissociation from positive posttranscriptional regulation. AIDS Res Hum Retroviruses (1996) 0.75
Sequence analysis of the new human T cell leukemia/lymphoma virus type I isolate (HTLV-I) in Israel. Isr J Med Sci (1994) 0.75
Fiber type morphometry and capillary geometry in free, vascularized muscle transfers. Microsurgery (1991) 0.75